title: 2-Chlorodeoxyadenosine treatment in the Sezary syndrome.
authors.forename: J M
authors.initials: JM
authors.lastname: Zaucha
authors.forename: K
authors.initials: K
authors.lastname: Lewandowski
authors.forename: A
authors.initials: A
authors.lastname: Hellmann
authors.forename: H
authors.initials: H
authors.lastname: Pawlik
authors.forename: A
authors.initials: A
authors.lastname: Siedlewicz
mesh_terms: D000328:Adult; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use*; D017338:Cladribine / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007239:Infections / Q000209:etiology; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced / Q000150:complications; D012751:Sezary Syndrome / Q000188:drug therapy*; D013921:Thrombocytopenia / Q000139:chemically induced; D017211:Treatment Failure
chemical_list: D000964:Antimetabolites, Antineoplastic; D017338:Cladribine